Helicobacter pylori are leading cause for chronic gastritis. People with this symptom are likely to develop peptic ulcer and in worst cases gastric cancer. The antibiotic therapy for H.Pylori fails to achieve success in different cases. This happens because the chronic form of the disease increases resistance to antibodies.
Lactobacillus reuteri has been found to reduce the Helicobacter pylori load in H.Pylori positive patients in an experiment conducted over 28 days using the supplement. There were trends towards reduction of the H. pylori load and no side effects were also cited in the study. The results revealed that lactobacillus reuteri has the potential to suppress the H.Pylori infection and also may lead to a complete improvement of the gastrointestinal symptoms shown due to the existence of H.Pylori.
Almost 50% of the global population has gastric symptoms and among them 20% advance to a more severe stages of the disease. H.Pylori infection varies from region. It affects few people in the developed countries and occurs more commonly in Africa, south America, Asia and East Europe.